|
Name |
2,4,5-Trimethylthiazole
|
| Molecular Formula | C6H9NS | |
| IUPAC Name* |
2,4,5-trimethyl-1,3-thiazole
|
|
| SMILES |
CC1=C(SC(=N1)C)C
|
|
| InChI |
InChI=1S/C6H9NS/c1-4-5(2)8-6(3)7-4/h1-3H3
|
|
| InChIKey |
BAMPVSWRQZNDQC-UHFFFAOYSA-N
|
|
| Synonyms |
2,4,5-Trimethylthiazole; 13623-11-5; Trimethylthiazole; Thiazole, trimethyl-; trimethyl thiazole; 2,4,5-Trimethyl-1,3-thiazole; Thiazole, 2,4,5-trimethyl-; FEMA No. 3325; trimethyl-1,3-thiazole; 2,4,5-trimethyl thiazole; NSC-170614; 6393273PE0; trimethyl-thiazole; UNII-6393273PE0; EINECS 237-107-9; MFCD00005332; NSC 170614; 2,5-Trimethylthiazole; 2,4,5-trimethylthiazol; Thiazole,4,5-trimethyl-; 2,4,5-Trimethyl-Thiazole; SCHEMBL77218; DTXSID5065564; CHEBI:78738; FEMA 3325; 2,4,5-Trimethylthiazole, 98%; ZINC407028; THIAZOLE, 2,4,5-TRIMETHYL; 2,4,5-Trimethyl-1,3-thiazole #; NSC170614; AKOS015842579; 2,4,5-Trimethylthiazole, >=98%, FG; BS-42217; 2,4,5-TRIMETHYL THIAZOLE [FHFI]; DB-003801; CS-0153587; FT-0609820; T1068; Thiazole, 2,4,5-trimethyl- (8CI)(9CI); D92445; EN300-722349; A807044; Q-100138; Q27147934
|
|
| CAS | 13623-11-5 | |
| PubChem CID | 61653 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 127.21 | ALogp: | 2.2 |
| HBD: | 0 | HBA: | 2 |
| Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 41.1 | Aromatic Rings: | 1 |
| Heavy Atoms: | 8 | QED Weighted: | 0.522 |
| Caco-2 Permeability: | -4.341 | MDCK Permeability: | 0.00002980 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.002 |
| Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.509 |
| 30% Bioavailability (F30%): | 0.826 |
| Blood-Brain-Barrier Penetration (BBB): | 0.989 | Plasma Protein Binding (PPB): | 60.19% |
| Volume Distribution (VD): | 1.967 | Fu: | 26.94% |
| CYP1A2-inhibitor: | 0.791 | CYP1A2-substrate: | 0.943 |
| CYP2C19-inhibitor: | 0.435 | CYP2C19-substrate: | 0.839 |
| CYP2C9-inhibitor: | 0.056 | CYP2C9-substrate: | 0.432 |
| CYP2D6-inhibitor: | 0.091 | CYP2D6-substrate: | 0.682 |
| CYP3A4-inhibitor: | 0.042 | CYP3A4-substrate: | 0.61 |
| Clearance (CL): | 7.998 | Half-life (T1/2): | 0.27 |
| hERG Blockers: | 0.006 | Human Hepatotoxicity (H-HT): | 0.078 |
| Drug-inuced Liver Injury (DILI): | 0.537 | AMES Toxicity: | 0.064 |
| Rat Oral Acute Toxicity: | 0.041 | Maximum Recommended Daily Dose: | 0.029 |
| Skin Sensitization: | 0.201 | Carcinogencity: | 0.808 |
| Eye Corrosion: | 0.972 | Eye Irritation: | 0.993 |
| Respiratory Toxicity: | 0.433 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC000477 | ![]() |
0.343 | D0A5SE | ![]() |
0.174 | ||
| ENC000657 | ![]() |
0.333 | D05YBZ | ![]() |
0.172 | ||
| ENC000180 | ![]() |
0.250 | D0U3DU | ![]() |
0.167 | ||
| ENC000242 | ![]() |
0.250 | D0X0RI | ![]() |
0.167 | ||
| ENC001348 | ![]() |
0.250 | D0U2CV | ![]() |
0.167 | ||
| ENC000364 | ![]() |
0.250 | D06PQT | ![]() |
0.164 | ||
| ENC000909 | ![]() |
0.243 | D0H6VY | ![]() |
0.163 | ||
| ENC000181 | ![]() |
0.237 | D06GIP | ![]() |
0.163 | ||
| ENC000342 | ![]() |
0.237 | D01PJR | ![]() |
0.160 | ||
| ENC000240 | ![]() |
0.229 | D02LDV | ![]() |
0.159 | ||